Leonid Dubrovsky MD
Assistant Professor, Division of Pediatric Hematology/Oncology
Join to View Full Profile
3800 Reservoir Rd., NWWashington, DC 20007
Phone+1 202-444-7599
Dr. Dubrovsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Leonid Dubrovsky, MD, is a graduate of Jefferson University, College of Medicine. He completed his pediatric residency at Children’s National Medical Center and his hematology oncology fellowship at Memorial Sloan Kettering Cancer Center. Before joining the MedStar Georgetown staff as an assistant professor, Dr. Dubrovsky served on the Pediatric Hematology Oncology team at St. Jude Affiliate Clinic at Children’s Hospital in Baton Rouge.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Research, 2014 - 2015
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2011 - 2014
Children's National HospitalResidency, Pediatrics, 2007 - 2010
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2007
Thomas Jefferson UniversityMD, 2007
Certifications & Licensure
LA State Medical License 2016 - Present
DC State Medical License 2010 - 2022
NY State Medical License 2011 - 2016
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsA Phase 1b Study of Lenvatinib plus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116.Masatoshi Kudo, Richard S Finn, Masafumi Ikeda, Max W Sung, Ari D Baron
Liver Cancer. 2024-08-01 - 105 citationsLenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.Josep M Llovet, Masatoshi Kudo, Philippe Merle, Tim Meyer, Shukui Qin
The Lancet. Oncology. 2023-12-01 - 59 citationsRandomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Am...Josep M Llovet, Arndt Vogel, David C Madoff, Richard S Finn, Sadahisa Ogasawara
Cardiovascular and Interventional Radiology. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
